Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Get Free Report) have been given an average recommendation of "Moderate Buy" by the thirteen ratings firms that are currently covering the firm, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation, eight have given a buy recommendation and one has given a strong buy recommendation to the company. The average 12-month price target among brokers that have covered the stock in the last year is $97.67.
Several equities research analysts have issued reports on the stock. Citigroup lifted their price target on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the company a "buy" rating in a research note on Thursday, February 13th. Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a "hold" rating to a "buy" rating and lifted their price target for the company from $95.00 to $103.00 in a research note on Wednesday, January 8th. Finally, Wells Fargo & Company lifted their price objective on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the company an "overweight" rating in a research report on Friday, February 14th.
Read Our Latest Research Report on GEHC
Institutional Trading of GE HealthCare Technologies
Several hedge funds and other institutional investors have recently modified their holdings of GEHC. Mackenzie Financial Corp raised its stake in GE HealthCare Technologies by 0.9% in the 4th quarter. Mackenzie Financial Corp now owns 80,728 shares of the company's stock worth $6,311,000 after purchasing an additional 755 shares in the last quarter. Forum Financial Management LP raised its stake in GE HealthCare Technologies by 30.7% in the 4th quarter. Forum Financial Management LP now owns 7,953 shares of the company's stock worth $622,000 after purchasing an additional 1,869 shares in the last quarter. Toronto Dominion Bank raised its stake in GE HealthCare Technologies by 71.5% in the 4th quarter. Toronto Dominion Bank now owns 263,565 shares of the company's stock worth $20,606,000 after purchasing an additional 109,875 shares in the last quarter. Retirement Planning Group LLC NY acquired a new stake in GE HealthCare Technologies in the 4th quarter worth about $654,000. Finally, GF Fund Management CO. LTD. acquired a new stake in GE HealthCare Technologies in the 4th quarter worth about $7,656,000. Institutional investors own 82.06% of the company's stock.
GE HealthCare Technologies Stock Down 1.1 %
GEHC stock traded down $1.00 during midday trading on Friday, hitting $91.09. The company's stock had a trading volume of 2,853,356 shares, compared to its average volume of 2,608,941. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 0.83. GE HealthCare Technologies has a twelve month low of $74.51 and a twelve month high of $94.80. The company's fifty day moving average price is $85.05 and its 200 day moving average price is $85.83. The stock has a market capitalization of $41.66 billion, a P/E ratio of 21.04, a PEG ratio of 3.19 and a beta of 1.15.
GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last issued its quarterly earnings results on Thursday, February 13th. The company reported $1.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.26 by $0.19. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. The firm had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.33 billion. As a group, equities research analysts predict that GE HealthCare Technologies will post 4.68 EPS for the current year.
About GE HealthCare Technologies
(
Get Free ReportGE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.
Further Reading
Before you consider GE HealthCare Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and GE HealthCare Technologies wasn't on the list.
While GE HealthCare Technologies currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
